Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Taiwan - Delayed Quote TWD

Pegavision Corporation (6491.TW)

Compare
360.00
0.00
(0.00%)
At close: April 2 at 1:30:10 PM GMT+8
Loading Chart for 6491.TW
  • Previous Close 360.00
  • Open 360.00
  • Bid 360.50 x --
  • Ask 361.00 x --
  • Day's Range 355.50 - 362.00
  • 52 Week Range 350.00 - 548.00
  • Volume 148,351
  • Avg. Volume 237,459
  • Market Cap (intraday) 28.08B
  • Beta (5Y Monthly) 1.37
  • PE Ratio (TTM) 15.48
  • EPS (TTM) 23.26
  • Earnings Date Apr 21, 2025 - Apr 25, 2025
  • Forward Dividend & Yield 10.00 (2.78%)
  • Ex-Dividend Date Jun 19, 2024
  • 1y Target Est 418.20

Pegavision Corporation manufactures and sells medical devices, and optical and precision instruments in Taiwan. It offers soft contact lenses for OEM customers and wearers. The company was founded in 2009 and is based in Taoyuan City, Taiwan. Pegavision Corporation is a subsidiary of Kinsus Interconnect Technology Corp.

www.pegavision.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 6491.TW

View More

Performance Overview: 6491.TW

Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

6491.TW
4.51%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
7.54%

1-Year Return

6491.TW
24.31%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
4.06%

3-Year Return

6491.TW
23.36%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
20.84%

5-Year Return

6491.TW
299.55%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
120.40%

Compare To: 6491.TW

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6491.TW

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    28.08B

  • Enterprise Value

    24.83B

  • Trailing P/E

    15.49

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.16

  • Price/Book (mrq)

    2.56

  • Enterprise Value/Revenue

    3.64

  • Enterprise Value/EBITDA

    8.50

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    26.85%

  • Return on Assets (ttm)

    9.18%

  • Return on Equity (ttm)

    17.62%

  • Revenue (ttm)

    6.82B

  • Net Income Avi to Common (ttm)

    1.83B

  • Diluted EPS (ttm)

    23.26

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.26B

  • Total Debt/Equity (mrq)

    9.18%

  • Levered Free Cash Flow (ttm)

    -1.22B

Research Analysis: 6491.TW

View More

Company Insights: 6491.TW

Research Reports: 6491.TW

View More

People Also Watch